Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '[S-35]GTP gamma S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 171 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ichikawa, D; Ozaki, S; Azuma, T; Nambu, H; Kawamoto, H; Iwasawa, Y; Takeshima, H; Ohta, H
      In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated [S-35]GTP gamma S binding to mouse brain

      NEUROREPORT
    2. Xu, H; Lu, YF; Thomas, JB; Carroll, FI; Rice, KC; Rothman, RB
      Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4 piperidinyl) phenylamino]-N,N-diethylbenzamide and related compoundsat the cloned human delta-opioid receptor

      SYNAPSE
    3. Xu, H; Lu, YF; Rice, KC; Ananthan, S; Rothman, RB
      SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [S-35]-GTP-gamma-S binding at cloned opioid receptors

      BRAIN RESEARCH BULLETIN
    4. Mizoguchi, H; Wu, HE; Narita, M
      Partial agonistic action of endomorphins in the mouse spinal cord

      NEUROSCIENCE LETTERS
    5. Selkirk, JV; Price, GW; Nahorski, SR; Challiss, RAJ
      Cell type-specific differences in the coupling of recombinant mGlu1 alpha receptors to endogenous G protein sub-populations

      NEUROPHARMACOLOGY
    6. Dupuis, DS; Wurch, T; Tardif, S; Colpaert, FC; Pauwels, PJ
      Modulation of 5-HT1A receptor activation by its interaction with wild-typeand mutant G(alpha i3) proteins

      NEUROPHARMACOLOGY
    7. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    8. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    9. Kushner, SA; Unterwald, EM
      Chronic cocaine administration decreases the functional coupling of GABA(B) receptors in the rat ventral tegmental area as measured by baclofen-stimulated S-35-GTP gamma S binding

      LIFE SCIENCES
    10. Spetea, M; Harris, HE; Berzetei-Gurske, IP; Klareskog, L; Schmidhammer, H
      Binding, pharmacological and immunological profiles of the delta-selectiveopioid receptor antagonist HS 378

      LIFE SCIENCES
    11. Hosohata, Y; Varga, EV; Stropova, D; Li, XP; Knapp, RJ; Hruby, VJ; Rice, KC; Nagase, H; Roeske, WR; Yamamura, HI
      Mutation W284L of the human delta opioid receptor reveals agonist specificreceptor conformations for G protein activation

      LIFE SCIENCES
    12. Daunais, JB; Letchworth, SR; Sim-Selley, LJ; Smith, HR; Childers, SR; Porrino, LJ
      Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate

      JOURNAL OF COMPARATIVE NEUROLOGY
    13. Zaveri, N; Polgar, WE; Olsen, CM; Kelson, AB; Grundt, P; Lewis, JW; Toll, L
      Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Koek, W; Vacher, B; Cosi, C; Assie, MB; Patoiseau, JF; Pauwels, PJ; Colpaert, FC
      5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Sim-Selley, LJ; Brunk, LK; Selley, DE
      Inhibitory effects of SR141716A on G-protein activation in rat brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Umland, SP; Wan, Y; Shah, H; Billah, M; Egan, RW; Hey, JA
      Receptor reserve analysis of the human alpha(2C)-adrenoceptor using [S-35]GTP gamma S and cAMP functional assays

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Savinainen, JR; Jarvinen, T; Laine, K; Laitinen, JT
      Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Pauwels, PJ; Tardif, S; Wurch, T; Colpaert, FC
      Real-time analysis of dopamine: antagonist interactions at recombinant human D-2long receptor upon modulation of its activation state

      BRITISH JOURNAL OF PHARMACOLOGY
    19. Nickel, T; Bauer, U; Schlicker, E; Kathmann, M; Gothert, M; Sasse, A; Stark, H; Schunack, W
      Novel histamine H-3-receptor antagonists and partial agonists with a non-aminergic structure

      BRITISH JOURNAL OF PHARMACOLOGY
    20. Akam, EC; Challiss, RAJ; Nahorski, SR
      G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype

      BRITISH JOURNAL OF PHARMACOLOGY
    21. Griffin, G; Williams, S; Aung, MM; Razdan, RK; Martin, BR; Abood, ME
      Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues

      BRITISH JOURNAL OF PHARMACOLOGY
    22. Narita, M; Mizoguchi, H; Nagase, H; Suzuki, T; Tseng, LF
      Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment

      BRAIN RESEARCH
    23. Hong, WM; Werling, L
      Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum

      BRAIN RESEARCH
    24. Pauwels, PJ; Tardif, S; Colpaert, FC
      Differential signalling of both wild-type and Thr(343) Arg dopamine D-2short receptor by partial agonists in a G-protein-dependent manner

      BIOCHEMICAL PHARMACOLOGY
    25. Onali, P; Olianas, MC
      beta gamma-mediated enhancement of corticotropin-releasing hormone-stimulated adenylyl cyclase activity by activation of gamma-aminobutyric acid(B) receptors in membranes of rat frontal cortex

      BIOCHEMICAL PHARMACOLOGY
    26. Pauwels, PJ; Tardif, S; Colpaert, FC; Wurch, T
      Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins

      BIOCHEMICAL PHARMACOLOGY
    27. Kiel, S; Bruss, M; Bonisch, H; Gothert, M
      Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HGT(1B) receptor: changes in ligand binding, G-protein coupling and second messenger formation

      PHARMACOGENETICS
    28. Terasmaa, A; Andbjer, B; Fuxe, K; Rinken, A
      Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes

      NEUROREPORT
    29. Monory, K; Bryant, SD; Kertesz, I; Balboni, G; Guerrini, R; Toth, G; Salvadori, S; Lazarus, LH; Borsodi, A
      Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist

      NEUROREPORT
    30. Monory, K; Bourin, MC; Spetea, M; Tomboly, C; Toth, G; Matthes, HW; Kieffer, BL; Hanoune, J; Borsodi, A
      Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2

      EUROPEAN JOURNAL OF NEUROSCIENCE
    31. Anichtchik, OV; Huotari, M; Peitsaro, N; Haycock, JW; Mannisto, PT; Panula, P
      Modulation of histamine H-3 receptors in the brain of 6-hydroxydopamine-lesioned rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    32. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
      Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

      SYNAPSE
    33. Nonno, R; Lucini, V; Spadoni, G; Pannacci, M; Croce, A; Esposti, D; Balsamini, C; Tarzia, G; Fraschini, F; Stankov, BM
      A new melatonin receptor ligand with mt(1)-agonist and MT2-antagonist properties

      JOURNAL OF PINEAL RESEARCH
    34. Rodriguez-Puertas, R; Gonzalez-Maeso, J; Meana, JJ; Pazos, A
      Autoradiography of receptor-activated G-proteins in post mortem human brain

      NEUROSCIENCE
    35. Mizoguchi, H; Narita, M; Wu, HE; Narita, M; Suzuki, T; Nagase, H; Tseng, LF
      Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla

      NEUROSCIENCE
    36. Rodriguez, RE; Barrallo, A; Garcia-Malvar, F; McFadyen, IJ; Gonzalez-Sarmiento, R; Traynor, JR
      Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio)

      NEUROSCIENCE LETTERS
    37. Platzer, S; Winkler, A; Schadrack, J; Dworzak, D; Tolle, TR; Zieglgansberger, W; Spanagel, R
      Autoradiographic distribution of mu-, delta- and kappa(1)-opioid stimulated [S-35]guanylyl-5 '-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum

      NEUROSCIENCE LETTERS
    38. Alberts, GL; Pregenzer, JF; Im, WB; Slightom, JL
      Cloning of serotonin 5-HT1 receptor subtypes from the chimpanzee, gorilla and Rhesus monkey and their agonist-induced guanosine 5'gamma S-35 triphosphate binding

      NEUROSCIENCE LETTERS
    39. Terasmaa, A; Finnman, UB; Owman, C; Ferre, S; Fuxe, K; Rinken, A
      Modulation of [S-35]GTP gamma S binding to Chinese hamster ovary cell membranes by D-2(short) dopamine receptors

      NEUROSCIENCE LETTERS
    40. Shapira, M; Vogel, Z; Sarne, Y
      Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    41. Burnside, JL; Rodriguez, L; Toll, L
      Species differences in the efficacy of compounds at the nociceptin receptor (ORL1)

      PEPTIDES
    42. Knapp, DJ; Sim-Selley, LJ; Breese, GR; Overstreet, DH
      Selective breeding of 5-HT1A receptor-mediated responses: application to emotion and receptor action

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    43. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      [S-35]-GTP gamma S autoradiography reveals alpha(2) adenoceptor-mediated G-protein activation in amygdala and lateral septum

      NEUROPHARMACOLOGY
    44. Moore, RJ; Xiao, RY; Sim-Selley, LJ; Childers, SR
      Agonist-stimulated [S-35]GTP gamma S binding in brain - Modulation by endogenous adenosine

      NEUROPHARMACOLOGY
    45. Gilliland, SL; Alper, RH
      Characterization of dopaminergic compounds at hD(2short), hD(4.2) and hD(4.7) receptors in agonist-stimulated [S-35]GTP gamma S binding assays

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    46. Gazi, L; Schoeffter, P; Nunn, C; Croskery, K; Hoyer, D; Feuerbach, D
      Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D-4 receptor

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    47. Nakazi, M; Bauer, U; Nickel, T; Kathmann, M; Schlicker, E
      Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    48. Maruo, J; Yoshida, A; Shimohira, I; Matsuno, K; Mita, S; Ueda, H
      Binding of [S-35]GTP gamma S stimulated by (+)-pentazocine, sigma receptoragonist, is abundant in the guinea pig spleen

      LIFE SCIENCES
    49. Mizoguchi, H; Narita, M; Nagase, H; Tseng, LF
      Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors

      LIFE SCIENCES
    50. Romero, J; Berrendero, F; Perez-Rosado, A; Manzanares, J; Rojo, A; Fernandez-Ruiz, JJ; de Yebenes, JG; Ramos, JA
      Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neuronsincreased CB1 receptor mRNA levels in the caudate-putamen

      LIFE SCIENCES
    51. McLoughlin, DJ; Strange, PG
      Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors

      JOURNAL OF NEUROCHEMISTRY
    52. Neilan, CL; Kenyon, E; Kovach, MA; Bowden, K; Claycomb, WC; Traynor, JR; Bolling, SF
      An immortalized myocyte cell line, HL-1, expresses a functional delta-opioid receptor

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    53. Hong, WM; Werling, LL
      Evidence that the sigma(1) receptor is not directly coupled to G proteins

      EUROPEAN JOURNAL OF PHARMACOLOGY
    54. Bonner, G; Meng, F; Akil, H
      Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop

      EUROPEAN JOURNAL OF PHARMACOLOGY
    55. Cosi, C; Koek, W
      The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Remmers, AE; Clark, MJ; Alt, A; Medzihradsky, F; Woods, JH; Traynor, JR
      Activation of G protein by opioid receptors: role of receptor number and G-protein concentration

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. Gilliland, SL; Alper, RH; Levant, B
      Pharmacology of quinpirole-stimulated [S-35]GTP gamma S binding: discrepancy with receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Gonzalez-Maeso, J; Rodriguez-Puertas, R; Gabilondo, AM; Meana, JJ
      Characterization of receptor-mediated [S-35]GTP gamma S binding to cortical membranes from postmortem human brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Alper, RH; Nelson, DL
      Inactivation of 5-HT1A receptors in hippocampal and cortical homogenates

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Sim-Selley, LJ; Vogt, LJ; Xiao, RY; Childers, SR; Selley, DE
      Region-specific changes in 5-HT1A receptor-activated G-proteins in rat brain following chronic buspirone

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Olianas, MC; Maullu, C; Adem, A; Mulugeta, E; Karlsson, E; Onali, P
      Inhibition of acetylcholine muscarinic M-1 receptor function by the M-1-selective ligand muscarinic toxin 7 (MT-7)

      BRITISH JOURNAL OF PHARMACOLOGY
    62. Alberts, GL; Pregenzer, JF; Im, WB
      Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells

      BRITISH JOURNAL OF PHARMACOLOGY
    63. Selley, DE; Cao, CC; Liu, QX; Childers, SR
      Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus

      BRITISH JOURNAL OF PHARMACOLOGY
    64. He, L; Di Monte, DA; Langston, JW; Quik, M
      Autoradiographic analysis of dopamine receptor-stimulated [S-35]GTP gamma S binding in rat striatum

      BRAIN RESEARCH
    65. Mize, AL; Alper, RH
      Acute and long-term effects of 17 beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [S-35]GTP gamma S binding

      BRAIN RESEARCH
    66. Meschler, JP; Kraichely, DM; Wilken, GH; Howlett, AC
      Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxypheny-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor

      BIOCHEMICAL PHARMACOLOGY
    67. Maher, CE; Selley, DE; Childers, SR
      Relationship of Mu opioid receptor binding to activation of G-proteins in specific rat brain regions

      BIOCHEMICAL PHARMACOLOGY
    68. Vanhauwe, JFM; Ercken, M; van de Wiel, D; Jurzak, M; Leysen, JE
      Effects of recent and reference antipsychotic agents at human dopamine D-2and D-3 receptor signaling in Chinese hamster ovary cells

      PSYCHOPHARMACOLOGY
    69. Olianas, MC; Maullu, C; Ingianni, A; Onali, P
      [Phe(1)Phi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells

      NEUROREPORT
    70. Rinken, A; Ferre, S; Terasmaa, A; Owman, C; Fuxe, K
      Serotonergic agonists behave as partial agonists at the dopamine D-2 receptor

      NEUROREPORT
    71. Dupuis, DS; Pauwels, PJ; Radu, D; Hall, H
      Autoradiographic studies of 5-HT1A-receptor-stimulated [S-35]GTP gamma S-binding responses in the human and monkey brain

      EUROPEAN JOURNAL OF NEUROSCIENCE
    72. Millan, MJ; Gobert, A; Audinot, V; Dekeyne, A; Newman-Tancredi, A
      Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo

      NEUROPSYCHOPHARMACOLOGY
    73. Olianas, MC; Maullu, C; Onali, P
      Mixed agonist-antagonist properties of clozapine at different human clonedmuscarinic receptor subtypes expressed in Chinese hamster ovary cells

      NEUROPSYCHOPHARMACOLOGY
    74. Garcia-Gil, L; De Miguel, R; Romero, J; Perez, A; Ramos, JA; Fernandez-Ruiz, JJ
      Perinatal Delta(9)-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists inadult rats

      NEUROTOXICOLOGY AND TERATOLOGY
    75. Sim-Selley, LJ; Daunais, JB; Porrino, LJ; Childers, SR
      Mu and kappa(1) opioid-stimulated [S-35]guanylyl-5 '-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain

      NEUROSCIENCE
    76. Mizoguchi, H; Narita, M; Oji, DE; Suganuma, C; Nagase, H; Sora, I; Uhl, GR; Cheng, EY; Tseng, LF
      The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice

      NEUROSCIENCE
    77. May, T; Juilfs, F; Wolffgramm, J
      Effects of etonitazene consumption and abstinence on the signal transmission of mu-opioid receptors in brain membranes of rats

      NEUROSCIENCE LETTERS
    78. Romero, J; Berrendero, F; Garcia-Gil, L; Lin, SY; Makriyannis, A; Ramos, JA; Fernandez-Ruiz, JJ
      Cannabinoid receptor and WIN-55,212-2-stimulated [S-35]GTP gamma S bindingand cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide

      NEUROCHEMISTRY INTERNATIONAL
    79. Fraser, GL; Labarre, M; Godbout, C; Butterworth, J; Clarke, PBS; Payza, K; Schmidt, R
      Characterization of [I-125]AR-M100613, a high-affinity radioligand for delta opioid receptors

      PEPTIDES
    80. Dupuis, DS; Perez, M; Halazy, S; Colpaert, FC; Pauwels, PJ
      Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [S-35]GTP gamma S binding responses

      MOLECULAR BRAIN RESEARCH
    81. Corchero, J; Romero, J; Berrendero, F; Fernandez-Ruiz, J; Ramos, JA; Fuentes, JA; Manzanares, J
      Time-dependent differences of repeated administration with Delta(9)-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen

      MOLECULAR BRAIN RESEARCH
    82. Dupuis, DS; Tardif, S; Wurch, T; Colpaert, FC; Pauwels, PJ
      Modulation of 5-MT1A receptor signalling by point-mutation of cysteine(351) in the rat G(alpha o) protein

      NEUROPHARMACOLOGY
    83. Hyytia, P; Ingman, K; Soini, SL; Laitinen, JT; Korpi, ER
      Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    84. Kathmann, M; Bauer, U; Schlicker, E
      CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    85. Newman-Tancredi, A; Cussac, D; Audinot, V; Millan, MJ
      Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    86. Olianas, MC; Onali, P
      PD 102807, a novel muscarinic M-4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP

      LIFE SCIENCES
    87. Geurts, M; Hermans, E; Maloteaux, JM
      Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [S-35]GTP gamma S binding

      LIFE SCIENCES
    88. Tsuji, M; Narita, M; Mizoguchi, H; Narita, M; Ohsawa, M; Kamei, J; Nagase, H; Takeda, H; Matsumiya, T; Tseng, LF
      Region-dependent G-protein activation by mu-, delta(1)- and delta(2)-opioid receptor agonists in the brain: Comparison between the midbrain and forebrain

      LIFE SCIENCES
    89. Gessi, S; Campi, F; Varani, K; Borea, PA
      alpha(2)-adrenergic agonist modulation of [S-35]GTP gamma S binding to guanine-nucleotide-binding-proteins in human platelet membranes

      LIFE SCIENCES
    90. Breivogel, CS; Childers, SR; Deadwyler, SA; Hampson, RE; Vogt, LJ; Sim-Selley, LJ
      Chronic Delta(9)-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteinsin rat brain

      JOURNAL OF NEUROCHEMISTRY
    91. Elliott, J; Reynolds, GP
      Agonist-stimulated GTP gamma[S-35] binding to 5-HT1A receptors in human post-mortem brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    92. Newman-Tancredi, A; Rivet, JM; Chaput, C; Touzard, M; Verriele, L; Millan, MJ
      The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study

      EUROPEAN JOURNAL OF PHARMACOLOGY
    93. Alberts, GL; Pregenzer, JF; Im, WB; Zaworski, PG; Gill, GS
      Agonist-induced GTP gamma S-35 binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    94. Geurts, M; Hermans, E; Maloteaux, JM
      Enhanced striatal dopamine D-2 receptor-induced [S-35]GTP gamma S binding after haloperidol treatment

      EUROPEAN JOURNAL OF PHARMACOLOGY
    95. Watson, JM; Hunter, AJ; Brown, AM; Middlemiss, DN
      In vitro characterisation of the muscarinic receptor partial agonist, sabcomeline, in rat cortical and heart membranes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    96. Ito, H; Maemoto, T; Akahane, A; Butcher, SP; Olverman, HJ; Finlayson, K
      Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A(1) receptors: [S-35]GTP gamma S binding studies

      EUROPEAN JOURNAL OF PHARMACOLOGY
    97. Narita, M; Mizoguchi, H; Oji, DE; Narita, M; Dun, NJ; Hwang, BH; Nagase, H; Tseng, LF
      Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [S-35]-GTP gamma S binding and immunohistochemistry

      BRITISH JOURNAL OF PHARMACOLOGY
    98. Monastyrskaia, K; Lundstrom, K; Plahl, D; Acuna, G; Schweitzer, C; Malherbe, P; Mutel, V
      Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monosodium glutamate taste transduction

      BRITISH JOURNAL OF PHARMACOLOGY
    99. Nonno, R; Pannacci, M; Lucini, V; Angeloni, D; Fraschini, F; Stankov, BM
      Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    100. Pregenzer, JF; Alberts, GL; Bin Im, W; Slightom, JL; Ennis, MD; Hoffman, RL; Ghazal, NB; TenBrink, RE
      Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)

      BRITISH JOURNAL OF PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 23:07:08